Spots Global Cancer Trial Database for Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

Official Title: Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

Study ID: NCT03904667

Conditions

Liver Resection

Interventions

Watson on oncology surgery decision evaluation

Study Description

Brief Summary: The aim of this study was to evaluate the surgical decisions of Watson artificial intelligence in patients with hepatocellular carcinoma.

Detailed Description: Hepatectomy is an effective treatment for patients with hepatocellular carcinoma, but liver failure after hepatectomy may lead to increased postoperative mortality. Therefore, it is very important to make preoperative surgical decisions, evaluate the safety of the operation and identify which patients are likely to suffer from liver failure. The artificial intelligence platform developed by IBM Watson for Watson tumor treatment decisions can provide treatment decisions and corresponding theoretical basis to guide surgical decisions based on the key clinical data of liver cancer patients.